×
About 35,625 results

ALLMedicine™ Human Papillomavirus Center

Research & Reviews  11,902 results

Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A popu...
https://doi.org/10.1080/21645515.2022.2083894
Human Vaccines & Immunotherapeutics; Dib F, Mayaud P et. al.

Jun 30th, 2022 - The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of this study was to identify factors associated with the uptake of the HPV vaccine in girls aged 11-14 years in France. We conducted a telephone survey among a qu...

A Case of Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma.
https://doi.org/10.1177/01455613221112334
Ear, Nose, & Throat Journal; Jung SM, Kim MK et. al.

Jun 30th, 2022 - Human papillomavirus (HPV)-related multiphenotypic sinonasal carcinoma (HMSC) is a recently described neoplasm entity that presents only in the sinonasal tract. Histologically, it displays features of both a surface-derived carcinoma and a salivar...

Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prog...
https://doi.org/10.1136/ijgc-2021-003251
International Journal of Gynecological Cancer : Official ... Thompson EF, Hoang L et. al.

Jun 29th, 2022 - Vulvar squamous cell carcinoma is subclassified into three prognostically relevant groups: (i) human papillomavirus (HPV) associated, (ii) HPV independent p53 abnormal (mutant pattern), and (iii) HPV independent p53 wild type. Immunohistochemistry...

Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than ...
https://doi.org/10.1097/LGT.0000000000000685
Journal of Lower Genital Tract Disease; Egemen D, Perkins RB et. al.

Jun 29th, 2022 - In the 2019 ASCCP Risk-Based Management Consensus Guidelines, clinical management decisions are based on immediate and 5-year cervical intraepithelial neoplasia (CIN) 3+ risk estimates. However, data for technologies other than human papillomaviru...

The relationship of 3'UTR HLA-G14-bp insertion/deletion and +3142 C/G polymorphisms and...
https://doi.org/10.1002/iid3.645
Immunity, Inflammation and Disease; Tizaoui K, Jalouli M et. al.

Jun 28th, 2022 - Human leukocyte antigen-G (HLA-G) is implicated in several cancers and is considered to be an immune checkpoint regulator. We determined the association between polymorphisms in the 3' untranslated region of HLA-G and soluble HLA-G (sHLA-G) expres...

see more →

Guidelines  42 results

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
https://doi.org/10.1016/j.jacr.2021.02.016
Journal of the American College of Radiology : JACR; , Lakhman Y et. al.

May 8th, 2021 - Vulvar cancer is an uncommon gynecologic tumor and one of several human papillomavirus-associated malignancies. Squamous cell carcinoma is the most prevalent histologic subtype of vulvar cancer, accounting for the majority of cases. Imaging plays ...

ASCCP Risk-Based Colposcopy Recommendations Applied in Thai Women With Atypical Squamou...
https://doi.org/10.1097/AOG.0000000000003982
Obstetrics and Gynecology; Phianpiset R, Ruengkhachorn I et. al.

Aug 10th, 2020 - To compare the proportion of cervical intraepithelial neoplasia (CIN) 2 or worse pathology among different risk strata according to the ASCCP when applied in women who had atypical squamous cells of undetermined significance (ASC-US) or low-grade ...

Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
https://doi.org/10.1097/AOG.0000000000004000
Obstetrics and Gynecology;

Aug 1st, 2020 - Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the mos...

Cervical cancer screening for individuals at average risk: 2020 guideline update from t...
https://doi.org/10.3322/caac.21628
CA: a Cancer Journal for Clinicians; Fontham ETH, Wolf AMD et. al.

Jul 31st, 2020 - The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV te...

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideli...
https://doi.org/10.3322/caac.21616
CA: a Cancer Journal for Clinicians; Saslow D, Andrews KS et. al.

Jul 9th, 2020 - The American Cancer Society (ACS) presents an adaptation of the current Advisory Committee on Immunization Practices recommendations for human papillomavirus (HPV) vaccination. The ACS recommends routine HPV vaccination between ages 9 and 12 years...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  673 results

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection
https://clinicaltrials.gov/ct2/show/NCT04247282

Jun 24th, 2022 - Background: Approximately 50% of patients with advanced, non-HPV associated head and neck squamous cell carcinoma (HNSCC) will develop locoregional or distant relapse within two years of completing definitive standard-of-care treatment. Two ongoin...

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
https://clinicaltrials.gov/ct2/show/NCT04097561

Jun 24th, 2022 - Idiopathic CD4 lymphopenia (ICL) is characterized by persistent low CD4 counts, frequently in combination with CD8, natural killer, or B cell lymphopenia. It is considered a heterogeneous disorder with manifestations that can include autoimmunity,...

Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
https://clinicaltrials.gov/ct2/show/NCT05026138

Jun 24th, 2022 - Study Design: This is a prospective, longitudinal natural history study. Total length of individual participation is 10 years. Primary Objective: To define the clinical, immunologic, and genetic bases of severe disseminated, recurrent, and treatme...

Early Detection of Esophageal Cancer
https://clinicaltrials.gov/ct2/show/NCT00341523

Jun 24th, 2022 - Esophageal squamous cell carcinoma (ESCC) is a major cause of death in the central Asian esophageal cancer belt and human papillomavirus (HPV) has been proposed as a potential cause. While several HPV-associated cancers have been identified (e.g.,...

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
https://clinicaltrials.gov/ct2/show/NCT01011712

Jun 24th, 2022 - Viral infections in the normal host are usually self-limited as the innate and acquired immune systems mount successful antiviral responses. However, in some instances, apparently immunocompetent persons manifest infections with viruses that would...

see more →

News  1,602 results

Provider Recommendation Key to Boosting Teen HPV Vaccines
https://www.medscape.com/viewarticle/976108

Jun 23rd, 2022 - Human papillomavirus (HPV) vaccination coverage of at least one dose significantly increased in U.S. adolescents from 56.1% in 2015 to 75.4% in 2020, according to the National Immunization Survey–Teen (NIS-Teen). The telephone survey, conducted am...

HPV Vaccination 'Unmasks' Cervical Lesions From Non-Vax Strains
https://www.medscape.com/viewarticle/975939

Jun 21st, 2022 - Vaccines against human papillomavirus (HPV) have been hailed as a success: they have been shown to decrease the incidence of cervical lesions associated with the HPV types that are in the vaccine. However, new evidence suggests that HPV vaccinatio...

California Lawmaker Scraps Plan for Preteen Vaccine Consent
https://www.medscape.com/viewarticle/975838

Jun 17th, 2022 - SACRAMENTO, Calif. (AP) — California lawmakers on Thursday amended a bill that would have let preteens be vaccinated against a range of health conditions without their parents' consent, instead raising the proposed minimum age to 15, which would s...

HPV Vaccination May Cut Risk of Recurrent Respiratory Papillomatosis
https://www.medscape.com/viewarticle/975743

Jun 17th, 2022 - NEW YORK (Reuters Health) - Receiving the quadrivalent human papillomavirus (HPV) vaccine is associated with a lower risk of recurrent respiratory papillomatosis (RRP) requiring surgery, according to results of a nonrandomized trial. "Because no d...

Is Hepatitis C an STI?
https://www.medscape.com/viewarticle/975794

Jun 17th, 2022 - A 32-year-old woman had sex with a man she met while on vacation 6 weeks ago. She was intoxicated at the time and does not know much about the person. She recalls having engaged in vaginal intercourse without a condom. She does not have any sympto...

see more →

Patient Education  20 results see all →